Report : North America Contraceptives Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Condoms, Intrauterine Product (IUDs), Vaginal Rings, Implants, Patches, Diaphragms, Emergency Contraceptives, Sponges, and Others), End User (Home Care, Hospitals and Clinics), and Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy)
Condoms Segment to Dominate North America Contraceptives Market during 2021–2028
According to a new market research study on “North America Contraceptives Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, End User, and Distribution Channel” is expected to reach US$ 15,386.11 million by 2028 from US$ 10,859.29 million in 2021. The market is estimated to grow at a CAGR of 5.1% from 2021 to 2028. The report provides trends prevailing in the North America contraceptives market along with the drivers and restraints pertaining to the market growth. Increasing rate of unwanted pregnancies is the major factor driving the growth of the North America contraceptives market. However, issues associated with the lack of adoption in low-income countries hinder the growth of North America contraceptives market.
The market for North America contraceptives market is segmented into product, end user, and distribution channel, and country. Based on product, the market is segmented condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment dominated the market in 2020 and intrauterine product (IUDs) segment is expected to be the fastest growing during the forecast period. Further, condoms has been bifurcated into female condoms and male condoms. Similarly intrauterine product (IUDs) is bifurcated into hormonal IUDs and copper IUDs. Based on end user, the market is segmented into home care, and hospitals and clinics. The home care segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on distribution channel, the market is segmented into retail pharmacy, online pharmacy, and hospital pharmacy. The retail pharmacy segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on country, the market has been segmented into US, Canada, and Mexico.
North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 30,521,774, with 555,314 deaths reported in the US as of March 22, 2021. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached 2,195,772, with 198,036 deaths. Similarly, in Canada, there are about 933,785 COVID cases, with 22,676 deaths reported so far.The pandemic is straining public health systems globally, interrupting and delaying many kinds of critical health care. A recent survey by the World Health Organization found that family planning and contraception are among the most frequently disrupted health services. 7 in 10 countries around the world are experiencing disruptions along with United States, Canada and Mexico. However, the COVID-19 pandemic does not disrupt the supply of and demand generation for condoms. Sexual relations may be transformed in the new context of the pandemic, but they have not stopped. While access to male and female condoms has been critical in the global response to reduce HIV, sexually transmitted infections (STIs), and unintended pregnancies over the past three decades, these gains can be lost if condoms are not included in the essential commodities that are freely available to populations during the lockdown of countries. This brief for country condom program managers and experts provides a summary of relevant actions to sustain supplies of male condoms, female condoms, and lubricants and to adjust approaches for condom promotion during the time of COVID-19. However, in the long run, market is expected to boost the demand, as IUDs centers now opening for patients for reproductive health other than COVID -19.
Bayer AG; Church & Dwight, Inc.; CooperSurgical (Cooper Companies, Inc.); Mayer Laboratories, Inc.; Medicines360; Merck & Co., Inc.; and Prosan International B.V. are among the leading companies in the North America contraceptives market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
Contact Person: Sameer Joshi
Email Id: email@example.com